vs

Side-by-side financial comparison of CBIZ, Inc. (CBZ) and NU SKIN ENTERPRISES, INC. (NUS). Click either name above to swap in a different company.

CBIZ, Inc. is the larger business by last-quarter revenue ($848.6M vs $370.3M, roughly 2.3× NU SKIN ENTERPRISES, INC.). CBIZ, Inc. runs the higher net margin — 19.0% vs 3.9%, a 15.1% gap on every dollar of revenue. On growth, CBIZ, Inc. posted the faster year-over-year revenue change (1.3% vs -16.9%). NU SKIN ENTERPRISES, INC. produced more free cash flow last quarter ($5.9M vs $-28.5M). Over the past eight quarters, CBIZ, Inc.'s revenue compounded faster (42.1% CAGR vs -5.8%).

CBIZ, Inc. is a national provider of financial, insurance and advisory services headquartered in Independence, Ohio. CBIZ is one of the largest accounting, insurance brokerage, financial and advisory services providers in the United States with more than 120 offices and nearly 7,000 employees. Its common stock has been traded on the New York Stock Exchange since 1996, under the symbol "CBZ" since 1997.

Nu Skin Enterprises, Inc. is an American multilevel marketing company that develops and sells personal care products and dietary and nutritional supplements. Under the Nu Skin and Pharmanex brands, the company sells its products in 54 markets through a network of approximately 1.2 million independent distributors.

CBZ vs NUS — Head-to-Head

Bigger by revenue
CBZ
CBZ
2.3× larger
CBZ
$848.6M
$370.3M
NUS
Growing faster (revenue YoY)
CBZ
CBZ
+18.1% gap
CBZ
1.3%
-16.9%
NUS
Higher net margin
CBZ
CBZ
15.1% more per $
CBZ
19.0%
3.9%
NUS
More free cash flow
NUS
NUS
$34.4M more FCF
NUS
$5.9M
$-28.5M
CBZ
Faster 2-yr revenue CAGR
CBZ
CBZ
Annualised
CBZ
42.1%
-5.8%
NUS

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CBZ
CBZ
NUS
NUS
Revenue
$848.6M
$370.3M
Net Profit
$161.6M
$14.5M
Gross Margin
70.7%
Operating Margin
23.2%
6.3%
Net Margin
19.0%
3.9%
Revenue YoY
1.3%
-16.9%
Net Profit YoY
140.1%
EPS (diluted)
$2.63
$0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBZ
CBZ
NUS
NUS
Q1 26
$848.6M
Q4 25
$542.7M
$370.3M
Q3 25
$693.8M
$364.2M
Q2 25
$683.5M
$386.1M
Q1 25
$838.0M
$364.5M
Q4 24
$460.3M
$445.6M
Q3 24
$438.9M
$430.1M
Q2 24
$420.0M
$439.1M
Net Profit
CBZ
CBZ
NUS
NUS
Q1 26
$161.6M
Q4 25
$-79.4M
$14.5M
Q3 25
$30.1M
$17.1M
Q2 25
$41.9M
$21.1M
Q1 25
$122.8M
$107.5M
Q4 24
$-90.7M
$-36.1M
Q3 24
$35.1M
$8.3M
Q2 24
$19.8M
$-118.3M
Gross Margin
CBZ
CBZ
NUS
NUS
Q1 26
Q4 25
-9.4%
70.7%
Q3 25
13.0%
70.5%
Q2 25
12.9%
68.8%
Q1 25
27.2%
67.8%
Q4 24
-13.4%
62.7%
Q3 24
16.6%
70.1%
Q2 24
12.8%
70.0%
Operating Margin
CBZ
CBZ
NUS
NUS
Q1 26
23.2%
Q4 25
-15.7%
6.3%
Q3 25
8.5%
5.9%
Q2 25
8.8%
8.0%
Q1 25
23.9%
-2.7%
Q4 24
-23.2%
-11.9%
Q3 24
11.3%
4.2%
Q2 24
7.5%
-28.6%
Net Margin
CBZ
CBZ
NUS
NUS
Q1 26
19.0%
Q4 25
-14.6%
3.9%
Q3 25
4.3%
4.7%
Q2 25
6.1%
5.5%
Q1 25
14.7%
29.5%
Q4 24
-19.7%
-8.1%
Q3 24
8.0%
1.9%
Q2 24
4.7%
-26.9%
EPS (diluted)
CBZ
CBZ
NUS
NUS
Q1 26
$2.63
Q4 25
$-1.22
$0.27
Q3 25
$0.48
$0.34
Q2 25
$0.66
$0.43
Q1 25
$1.91
$2.14
Q4 24
$-1.84
$-0.73
Q3 24
$0.70
$0.17
Q2 24
$0.39
$-2.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBZ
CBZ
NUS
NUS
Cash + ST InvestmentsLiquidity on hand
$28.7M
$239.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.9B
$805.2M
Total Assets
$4.6B
$1.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBZ
CBZ
NUS
NUS
Q1 26
$28.7M
Q4 25
$18.3M
$239.8M
Q3 25
$17.0M
$253.0M
Q2 25
$39.8M
$265.4M
Q1 25
$8.8M
$213.6M
Q4 24
$13.8M
$198.0M
Q3 24
$1.1M
$237.8M
Q2 24
$1.1M
$232.9M
Stockholders' Equity
CBZ
CBZ
NUS
NUS
Q1 26
$1.9B
Q4 25
$1.8B
$805.2M
Q3 25
$1.9B
$799.8M
Q2 25
$1.9B
$787.8M
Q1 25
$1.9B
$754.0M
Q4 24
$1.8B
$651.5M
Q3 24
$927.9M
$706.9M
Q2 24
$891.4M
$686.2M
Total Assets
CBZ
CBZ
NUS
NUS
Q1 26
$4.6B
Q4 25
$4.4B
$1.4B
Q3 25
$4.5B
$1.4B
Q2 25
$4.5B
$1.4B
Q1 25
$4.6B
$1.4B
Q4 24
$4.5B
$1.5B
Q3 24
$2.1B
$1.6B
Q2 24
$2.2B
$1.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBZ
CBZ
NUS
NUS
Operating Cash FlowLast quarter
$-25.5M
$16.6M
Free Cash FlowOCF − Capex
$-28.5M
$5.9M
FCF MarginFCF / Revenue
-3.4%
1.6%
Capex IntensityCapex / Revenue
2.9%
Cash ConversionOCF / Net Profit
-0.16×
1.15×
TTM Free Cash FlowTrailing 4 quarters
$240.5M
$46.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBZ
CBZ
NUS
NUS
Q1 26
$-25.5M
Q4 25
$143.6M
$16.6M
Q3 25
$24.0M
$27.5M
Q2 25
$113.1M
$35.8M
Q1 25
$-88.3M
$389.0K
Q4 24
$55.5M
$25.8M
Q3 24
$43.7M
$31.4M
Q2 24
$88.2M
$51.2M
Free Cash Flow
CBZ
CBZ
NUS
NUS
Q1 26
$-28.5M
Q4 25
$141.7M
$5.9M
Q3 25
$22.1M
$17.6M
Q2 25
$105.2M
$35.8M
Q1 25
$-93.4M
$-13.2M
Q4 24
$52.3M
$13.2M
Q3 24
$41.1M
$22.8M
Q2 24
$86.3M
$43.1M
FCF Margin
CBZ
CBZ
NUS
NUS
Q1 26
-3.4%
Q4 25
26.1%
1.6%
Q3 25
3.2%
4.8%
Q2 25
15.4%
9.3%
Q1 25
-11.2%
-3.6%
Q4 24
11.4%
3.0%
Q3 24
9.4%
5.3%
Q2 24
20.5%
9.8%
Capex Intensity
CBZ
CBZ
NUS
NUS
Q1 26
Q4 25
0.4%
2.9%
Q3 25
0.3%
2.7%
Q2 25
1.2%
0.0%
Q1 25
0.6%
3.7%
Q4 24
0.7%
2.8%
Q3 24
0.6%
2.0%
Q2 24
0.4%
1.9%
Cash Conversion
CBZ
CBZ
NUS
NUS
Q1 26
-0.16×
Q4 25
1.15×
Q3 25
0.79×
1.61×
Q2 25
2.70×
1.69×
Q1 25
-0.72×
0.00×
Q4 24
Q3 24
1.25×
3.79×
Q2 24
4.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBZ
CBZ

Financial Services (1)$740.3M87%
Benefits and Insurance Services$108.2M13%

NUS
NUS

Other$161.9M44%
Mainland China Segment$52.0M14%
Southeast Asia Pacific Segment$50.5M14%
Europe And Africa Segment$41.8M11%
Hong Kong Taiwan Segment$29.6M8%
South Korea Segment$28.4M8%
Rhyz Other Segment$6.1M2%

Related Comparisons